Stonebridge Capital Management Inc Sarepta Therapeutics, Inc. Call Options Transaction History
Stonebridge Capital Management Inc
- $234 Million
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding SRPT
# of Institutions
479Shares Held
79.3MCall Options Held
4.23MPut Options Held
1.21M-
Vanguard Group Inc Valley Forge, PA8.8MShares$1.3 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$880 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.89MShares$722 Million0.36% of portfolio
-
Capital International Investors Los Angeles, CA4.82MShares$711 Million0.13% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.34MShares$641 Million6.78% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $12.9B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...